Has Norbert Kased, MD received payments from drug or device companies?

Yes. Drug and device makers reported $574 in general payments to Norbert Kased, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Norbert Kased, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Norbert Kased, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Norbert Kased, MD

Radiation Oncology · Vista, CANPI 1639405178

Payments from drug & device makers

$574in general payments, 2019–2025

Across 4 payments — averaging $143.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Brainlab, Inc.$344
E.r. Squibb & Sons, L.L.C.$127
Progenics Pharmaceuticals, Inc.$91
Lilly USA, LLC$13

What the payments were for

Food & beverage$574100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Brainlab, Inc.	1	$344
E.r. Squibb & Sons, L.L.C.	1	$127
Progenics Pharmaceuticals, Inc.	1	$91
Lilly USA, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPDIVO$127

How this compares

$574 in reported general payments places this provider in the 50th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California →

Medicare billing

Part B allowed, 2024

$2,154,805

Medicare patients

347

Services billed

5,953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cevimeline Hcl	11	$2,335
Memantine Hcl	16	$965
Sucralfate	21	$829
Naloxone Hcl	11	$578
Tamsulosin Hcl	35	$530
Tadalafil	13	$523
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$423
Dexamethasone	22	$265
SsdSilver Sulfadiazine	11	$178
Lidocaine Hcl ViscousLidocaine Hcl	19	$170
Ondansetron OdtOndansetron	13	$129
Nystatin	17	$89
Famotidine	16	$75
Tramadol Hcl	18	$43

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Vista

Loren Mellla Jolla$10M
Hyun KimDuarte$6M
Megan DalyOrange$4.5M
Percy LeeIrvine$2.4M
Felix FengSan Francisco$1.8M
Jeffrey WongDuarte$1.7M
Arta MonjazebSacramento$1.5M
Rakesh PatelLos Gatos$1.3M
Maximilian DiehnStanford$1.2M
Rizwan NuraniApple Valley$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →